Correlation Between Valbiotis SAS and Kalray SA
Can any of the company-specific risk be diversified away by investing in both Valbiotis SAS and Kalray SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valbiotis SAS and Kalray SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valbiotis SAS and Kalray SA, you can compare the effects of market volatilities on Valbiotis SAS and Kalray SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valbiotis SAS with a short position of Kalray SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valbiotis SAS and Kalray SA.
Diversification Opportunities for Valbiotis SAS and Kalray SA
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Valbiotis and Kalray is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Valbiotis SAS and Kalray SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalray SA and Valbiotis SAS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valbiotis SAS are associated (or correlated) with Kalray SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalray SA has no effect on the direction of Valbiotis SAS i.e., Valbiotis SAS and Kalray SA go up and down completely randomly.
Pair Corralation between Valbiotis SAS and Kalray SA
Assuming the 90 days trading horizon Valbiotis SAS is expected to generate 0.22 times more return on investment than Kalray SA. However, Valbiotis SAS is 4.51 times less risky than Kalray SA. It trades about 0.04 of its potential returns per unit of risk. Kalray SA is currently generating about -0.01 per unit of risk. If you would invest 133.00 in Valbiotis SAS on September 26, 2024 and sell it today you would earn a total of 6.00 from holding Valbiotis SAS or generate 4.51% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.46% |
Values | Daily Returns |
Valbiotis SAS vs. Kalray SA
Performance |
Timeline |
Valbiotis SAS |
Kalray SA |
Valbiotis SAS and Kalray SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Valbiotis SAS and Kalray SA
The main advantage of trading using opposite Valbiotis SAS and Kalray SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valbiotis SAS position performs unexpectedly, Kalray SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalray SA will offset losses from the drop in Kalray SA's long position.Valbiotis SAS vs. Kalray SA | Valbiotis SAS vs. Biosynex | Valbiotis SAS vs. Eurobio Scientific SA | Valbiotis SAS vs. OSE Pharma SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |